CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high

$6.72

Daily low

$6.44

Price at open

$6.58

52 Week High

$15.38

52 Week Low

$6.04

Market cap

1.1B

Dividend yield

0.00%

Volume

4.3M

Avg. volume

3.6M

P/E ratio

-645.63

Certara News